$MBRX· SEC filing ·

MBRX Reports $12M Revenue, $3.4M Net Income, Announces $20B Buyback

Moleculin Biotech, Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.79

+1.1% in 1h after detection

Post-detection moves

1h
+1.1%
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS